NIOX PRO vs NIOX VERO

NIOX VERO has become one of the most widely used FeNO machines in respiratory care, trusted by healthcare professionals worldwide for accurate, point-of-care FeNO testing. Building on this proven technology, NIOX PRO has been developed to offer the same trusted clinical performance while introducing several enhancements that improve workflow and usability.

Enhanced touchscreen and user experience

NIOX PRO features a larger, more responsive touchscreen with a redesigned user interface, making it easier for clinicians to navigate the device, access patient information and complete tests efficiently. The intuitive interface can help reduce training time and support faster adoption across busy primary and secondary care settings.

Improved portability

Designed with flexibility in mind, NIOX PRO has been refined to be even more portable thanks to its new strong mounted handle, making it well suited to being moved between consulting rooms.

image

FAQs

A FeNO asthma test is used alongside clinical assessment and other diagnostic tests to help identify eosinophilic airway inflammation. It can also support asthma monitoring by assessing how patients respond to inhaled corticosteroid treatment.
During a FeNO breathing test, the patient inhales fully before slowly exhaling into a FeNO machine at a controlled rate. The test is non-invasive, painless and typically produces results within a few minutes.
FeNO test results indicate the level of nitric oxide present in exhaled breath. Higher FeNO levels may suggest eosinophilic airway inflammation, while lower levels may indicate that this type of inflammation is less likely. Results should always be interpreted alongside clinical findings and current guidelines.
A FeNO machine provides an objective measurement of airway inflammation, helping improve diagnostic confidence and support personalised asthma care. It can also assist with treatment monitoring and discussions around medication adherence.
Yes. UK and international asthma guidelines recommend FeNO testing as part of the assessment of patients with suspected asthma, where appropriate, alongside clinical evaluation and other objective tests.
Yes. Repeated FeNO testing can help monitor airway inflammation over time, assess response to inhaled corticosteroids and support discussions about treatment adherence when used alongside clinical assessment.